We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Vitamin D Markedly Lowers Breast Cancer Risk

By HospiMedica International staff writers
Posted on 27 Jun 2018
Higher levels of serum 25-hydroxyvitamin D [25(OH)D] are associated with a significant decreased risk of breast cancer, according to a new study.

Researchers at the University of California, San Diego (UCSD, USA), GrassrootsHealth (Encinitas, CA, USA), and other institutions conducted an epidemiological study that pooled data from two randomized clinical trials for a total of 5,038 participants (average age 63 years) in order to examine the association between risk of female breast cancer and a broad range of 25(OH)D concentrations, the main form of vitamin D in blood. More...
All participants were free of cancer at enrollment and were followed for a mean period of four years.

The results showed 77 women were diagnosed with breast cancer. There was an 82% lower incidence rate of breast cancer for women with 25(OH)D concentrations higher that ng/ml ≥60, compared to those with concentrations lower than 20 ng/ml, with the highest proportion of breast cancer-free women in the 60 ng/ml and higher group (99.3%). Analysis revealed that after adjustment, women with 25(OH)D concentrations that were higher than 60 ng/ml had an 80% lower risk of breast cancer than those with concentrations lower than 20 ng/ml. The study was published on June 15, 2018, in PLOS One.

“To reach 25(OH)D levels of 60 ng/ml would generally require dietary supplements of 4,000 to 6,000 international units per day, less with the addition of moderate daily sun exposure wearing very minimal clothing,” said study co- author Professor Cedric Garland, PhD, of UCSD, who added that “the success of oral supplementation should be determined using a blood test, preferably during winter months.”

Vitamin D is a group of fat-soluble secosteroids found in many dietary sources, such as fish, eggs, fortified milk, and cod liver oil, which can also be synthesized in adequate amounts by all mammals from sunlight. Current recommended average daily amounts are 400 IU for children up to one year; 600 IU for ages one to 70 years (including pregnant or breastfeeding women), and 800 IU for persons over age 70, according to the U.S. National Academy of Medicine.

Related Links:
University of California, San Diego
GrassrootsHealth


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Dual Chamber Warming Cabinet
D-Series
New
Anesthesia Cart
UTGSU-333369-DKB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Minder Implant can record brain activity continuously for very long periods (Photo courtesy of Epiminder)

Implantable Device Continuously Monitors Brain Activity in Epileptic Patients

Epilepsy is one of the most prevalent and serious chronic neurological disorders, impacting around 52 million people globally. It is characterized by recurrent seizures, which are caused by abnormal electrical... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.